维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="DALENC F"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Manipulating protein acetyla- tion in breast cancer:a promising approach in combination with hormo- nal therapies? 显示文摘	Linares A Dalenc F Balaguer P	2011	J Biomed Biotechnol2011，2011，85：	1
	2	A phase Ⅰ dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first- line chemotherapy for metastatic breast cancer显示文摘	Delord JP Dalenc F Pinguet F	2007	Oncology2007，72，56：	1
	3	Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer:a negative phase II and screening of potential therapeutic markers by proteomic analysis显示文摘	DALENC F DOISNEAU-SIXOU S F ALLAL B C	2010	Clin Cancer Res2010，16，4：	1
	4	Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls ra- diation-induced centrosome overduplication 显示文摘	MILIA J TEYSSIER F DALENC F	2005	Cell Death Differ2005，12，：	1
	5	Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel显示文摘	Berliere M Dalenc F Malingret N	2008	BMC Cancer2008，8，56：	1
	6	A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER - 2 - overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy显示文摘	Hurvitz SA Dalenc F Campone M	2013	Breast Cancer Res Treat2013，141，3：	1
	7	Dexamethasone as a probe for vinorelbine clearance 显示文摘	Puisset F Dalenc F Chatelut E	2005	Br J Clin Pharmacol2005，60，1：	1
	8	Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel 显示文摘	Berliere M Dalenc F Malingret N	2008	BMC Cancer2008，8，1：	1
	9	A phase 2 study of everotimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy 显示文摘	Hurvitz SA Dalenc F Campone M	2013	Breast Cancer Res Treat2013，141，3：	1
	10	HFS-14,a specific quality of life scale developed for patients suffering from hand-foot syndrome显示文摘	Sibaud V Dalenc F Chevreau C	2011	Oncologist2011，16，10：	1
	11	Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel显示文摘	Berliere M Dalenc F Malingret N	2008	BMC Cance2008，8，56：	1
	12	Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel显示文摘	Berliere M Dalenc F Malingret N	2008	BMC Cancer2008，8，：	1
	13	A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy显示文摘	Hurvitz SA Dalenc F Campone M	2013	Breast Cancer Res Treat2013，141，3：	1
	14	Phase I study of lapatinib plus vinorelbine in patients with locally ad- vanced or metastatic breast cancer overexpressing HER2 显示文摘	Brain E Isambert N Dalenc F	2012	BrJCancer2012，106，4：	1
	15	Manipulating protein acetyla- tion in breast cancer: a promising approach in combination with hor-monal therapies?显示文摘	Linares A Dalenc F Balaguer P	2011	J Biomed Biotechnol2011，2011，85：	1
	16	RhoB controls the 24 kDa FGF-2-induced radioresistance in Hela cells by preventing post-mitotic cell death 显示文摘	Ader I Toulas C Dalenc F	2002	Oncogene2002，21，39：	1
	17	A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer显示文摘	Delord JP Dalenc F Pinguet F		0，，5：	1
	18	Decision -making and breast cancer clinical trials - How experience challenges attitudes 显示文摘	Mancini J Geneve J Dalenc F	2007	Contemp Clin Trials2007，28，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费